End-of-day quote
Korea S.E.
18:00:00 2024-05-13 EDT
|
5-day change
|
1st Jan Change
|
10,850
KRW
|
+0.28%
|
|
-0.18%
|
-1.45%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
---|
Capitalization
1 |
171,312
|
147,880
|
107,346
|
Enterprise Value (EV)
1 |
158,806
|
138,302
|
101,903
|
P/E ratio
|
53.8
x
|
19.4
x
|
26.5
x
|
Yield
|
-
|
0.67%
|
0.91%
|
Capitalization / Revenue
|
4.72
x
|
3.61
x
|
2.73
x
|
EV / Revenue
|
4.37
x
|
3.38
x
|
2.59
x
|
EV / EBITDA
|
18.9
x
|
14.5
x
|
9.86
x
|
EV / FCF
|
-
|
-30,704,404
x
|
-35,300,925
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
Price to Book
|
1.94
x
|
1.57
x
|
1.12
x
|
Nbr of stocks (in thousands)
|
9,960
|
9,859
|
9,759
|
Reference price
2 |
17,200
|
15,000
|
11,000
|
Announcement Date
|
22-03-21
|
22-03-21
|
23-03-20
|
Fiscal Period: December |
2020
|
2021
|
2022
|
---|
Net sales
1 |
36,318
|
40,914
|
39,299
|
EBITDA
1 |
8,421
|
9,547
|
10,337
|
EBIT
1 |
4,031
|
4,541
|
4,283
|
Operating Margin
|
11.1%
|
11.1%
|
10.9%
|
Earnings before Tax (EBT)
1 |
3,313
|
6,401
|
4,807
|
Net income
1 |
3,164
|
7,602
|
4,044
|
Net margin
|
8.71%
|
18.58%
|
10.29%
|
EPS
2 |
320.0
|
772.0
|
414.8
|
Free Cash Flow
|
-
|
-4,504
|
-2,887
|
FCF margin
|
-
|
-11.01%
|
-7.35%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
Dividend per Share
|
-
|
100.0
|
100.0
|
Announcement Date
|
22-03-21
|
22-03-21
|
23-03-20
|
Fiscal Period: December |
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
Net Cash position
1 |
12,506
|
9,579
|
5,443
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-4,504
|
-2,887
|
ROE (net income / shareholders' equity)
|
-
|
8.42%
|
4.3%
|
ROA (Net income/ Total Assets)
|
-
|
2.6%
|
2.35%
|
Assets
1 |
-
|
291,840
|
172,104
|
Book Value Per Share
2 |
8,880
|
9,528
|
9,859
|
Cash Flow per Share
2 |
1,246
|
1,162
|
812.0
|
Capex
1 |
15,404
|
14,311
|
7,104
|
Capex / Sales
|
42.42%
|
34.98%
|
18.08%
|
Announcement Date
|
22-03-21
|
22-03-21
|
23-03-20
|
|
1st Jan change
|
Capi.
|
---|
| -1.45% | 76.8M | | -11.92% | 77.05B | | +25.25% | 3.73B | | +1.95% | 3.33B | | +18.24% | 1.69B | | -8.73% | 1.52B | | -23.19% | 1.3B | | -2.34% | 1.27B | | -12.66% | 1.18B | | +0.24% | 1.09B |
Veterinary Drugs
|